Physician profile
Steven C Wu
NPI 1437519378
$1,352.18
in general payments reported to CMS, 2019-2025
16 companies · $789 in 2025
The $789 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $105 · 2024: $458 · 2025: $789.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,352.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $261.42 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Gilead Sciences, INC. | $224.81 | 2025 | Yeztugo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $158.14 | 2024-2025 | Jardiance |
| Glaxosmithkline, LLC. | $102.61 | 2023-2024 | Shingrix, Arexvy, Bexsero |
| Astrazeneca Pharmaceuticals LP | $96.65 | 2024-2025 | Airsupra |
| Abbvie INC. | $76.33 | 2024 | |
| Sanofi-Aventis U.S. LLC | $73.10 | 2024-2025 | |
| Novo Nordisk INC | $72.26 | 2025 | Wegovy, Ozempic |
| Abbott Laboratories | $58.21 | 2025 | Freestyle Libre 3 |
| Amgen INC. | $48.06 | 2025 | Prolia, Evenity |
| Exact Sciences Corporation | $41.90 | 2023-2024 | Cologuard Collection Kit |
| Astellas Pharma US INC | $37.63 | 2024-2025 | Veozah |
| Phadia US INC. | $33.98 | 2024 | Immunocap |
| Genzyme Corporation | $33.88 | 2024 | |
| Organon LLC | $18.56 | 2025 | Nexplanon |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $14.64 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.